RASSF1 and breast carcinoma: One of the first studies that proposed the use of epigenetic biomarkers in plasma to detect breast cancer compared four methylation biomarkers, APC, GSTP1, RASSF1A, and RARB, in primary breast cancer tissue and plasma samples.